Evidence map›Paper›PMID 40269694›Full record

ArticleBMC microbiology2025

Providencia pseudovermicola sp. nov.: redefining Providencia vermicola and unveiling multidrug-resistant strains from diabetic foot ulcers in Egypt.

Samira M Hamed, Manal M Darwish, Reham Monir, Ahmed Al Taweel, Ayat I Ghanem, Ihab N Hanna, Mai A Amer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. SAGE open medical case reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samira M HamedMicrobiology and Immunology Department, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, Egypt. satwa@msa.edu.eg.
Manal M DarwishMicrobiology and Immunology Department, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, Egypt.
Reham MonirNational Institute of Diabetes and Endocrinology (NIDE), Cairo, Egypt.
Ahmed Al TaweelNational Institute of Diabetes and Endocrinology (NIDE), Cairo, Egypt.
Ayat I GhanemNational Institute of Diabetes and Endocrinology (NIDE), Cairo, Egypt.
Ihab N HannaNational Institute of Diabetes and Endocrinology (NIDE), Cairo, Egypt.
Mai A AmerMicrobiology and Immunology Department, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA), Giza, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProvidencia species are concerning due to their intrinsic resistance to colistin and tigecycline, complicating the treatment of multidrug-resistant (MDR) infections.

methodsIn the current study, two MDR isolates, DFU6 and DFU52

resultsWhile the 16S rRNA gene showed 100% similarity to that of Providencia vermicola, phylogenomic analysis against the type strains in the TYGS database, including P. vermicola DSM 17385

conclusionFollowing our reassessment of the taxonomic classification of all P. vermicola strains with published genomes, we propose reclassifying certain strains, including DFU6 and DFU52

Indexed as

Diabetic FootDrug Resistance, Multiple, BacterialEnterobacteriaceae InfectionsProvidenciaAnti-Bacterial AgentsDNA, BacterialEgyptGenome, BacterialHumansMicrobial Sensitivity TestsPhylogenyRNA, Ribosomal, 16SWhole Genome SequencingAnti-Bacterial AgentsDNA, BacterialRNA, Ribosomal, 16SANIdDDHDiabetic foot ulcerMultidrug resistanceOGRIsProvidencia pseudovermicolaProvidencia spp.Providencia vermicolaTaxonogenomicsWhole genome sequencing

Identifiers

PMID40269694
PMCPMC12016157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.